(Q84703100)
Statements
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis (English)
Julie Briody
Peter J Simm
Mary McQuade
Brian Hsu
Corinne Bridge
David G Little
Christopher T Cowell